Nanobiotix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!About NBTX
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.
CEOLaurent Lévy
CEOLaurent Lévy
Employees97
Employees97
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded2003
Founded2003
Employees97
Employees97
NBTX Key Statistics
Market cap2.39B
Market cap2.39B
Price-Earnings ratio-86.53
Price-Earnings ratio-86.53
Dividend yield—
Dividend yield—
Average volume103.86K
Average volume103.86K
High today—
High today—
Low today—
Low today—
Open price$50.98
Open price$50.98
Volume946.00
Volume946.00
52 Week high$57.14
52 Week high$57.14
52 Week low$3.64
52 Week low$3.64
NBTX News
TipRanks 22h
Nanobiotix Reports Promising Phase 2 Data for NBTXR3 in Stage 3 Inoperable Lung CancerUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
TipRanks 1d
Nanobiotix price target raised to EUR 60 from EUR 34 at H.C. WainwrightH.C. Wainwright raised the firm’s price target on Nanobiotix (NBTX) to EUR 60 from EUR 34 and keeps a Buy rating on the shares after the company presented updat...
Analyst ratings
80%
of 10 ratingsBuy
80%
Hold
20%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.